ที่ FPI Ref. FPI.001/2020 25 February 2020 Subject : Management Discussion & Analysis of Performance Results of the year ended 2019 To : Board of Directors and President of The Stock Exchange of

ที่ FPI Ref. FPI.006/2019 10 May 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 1/2019 To : Board of Directors and President of The Stock Exchange of Thailand

ที่ FPI Ref. FPI.006/2019 14 August 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 2/2019 To : Board of Directors and President of The Stock Exchange of Thailand

ที่ FPI Ref. FPI.007/2019 14 August 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 2/2019 (edit) To : Board of Directors and President of The Stock Exchange of

Ref: ACC6401 / 001 March 01, 2021 Subject Clarification of Operating results for the year 2020, Ending December 31, 2020 Attention: Director and Manager The Stock Exchange of Thailand As Advanced

Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to

ที่ FPI Ref. FPI.007/2020 15 July 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 1 2020 To : Board of Directors and President of The Stock Exchange of Thailand

ที่ FPI Ref. FPI.011/2019 14 November 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2019 To : Board of Directors and President of The Stock Exchange of Thailand

transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65

Page 1 of 9 Ref. PDI/BK-BS-049/2017 31 August 2017 To: President The Stock Exchange of Thailand Re: Acquisition of shares in Symbior Elements Pte. Ltd. Enclosure: Information Memorandum regarding the